Home » Topics » BioWorld Science

BioWorld Science
RSS

Novartis presents new PCSK9 inhibitors

June 11, 2020

Merck & Co. describes new adenosine receptor antagonists

June 11, 2020

Exon-intron fusions play role in osteosarcoma metastases

June 11, 2020

Roche synthesizes new MGL inhibitors

June 11, 2020

U.K. researchers present BCL-6 inhibitors

June 11, 2020

Dana-Farber Cancer Institute and Voronoi patent DYRK1A inhibitors

June 11, 2020

First connection between an ARSD gene variant and disease identified

June 11, 2020

Modified peptides generate RA-specific CD4+ T cells with lytic properties against APCs

June 11, 2020

First-in-human data presented for ALT-P7 in advanced HER2-positive breast cancer

June 11, 2020

Interim phase I data for ONCOS-102 plus durvalumab in peritoneal malignancies

June 11, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...